Cardiovascular outcome trials up to 2023: it's all about LDL-C lowering

26 August 2023 (12:55 - 13:10)

Organised by:

Slides

Sign in to view the resources

About the speaker

Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

4 More presentations in this session

Presentation thumbnail

Setting the stage: LDL-C and cardiovascular risk

Professor L. Tokgozoglu (Ankara, TR)

Presentation thumbnail

Data from 2023: it’s still all about LDL-C lowering

Professor S. Nicholls (Melbourne, AU)

Presentation thumbnail

Panel discussion and Q&A

Professor L. Tokgozoglu (Ankara, TR) Professor U. Laufs (Leipzig, DE) Professor S. Nicholls (Melbourne, AU)

Presentation thumbnail

Summary and meeting close

Professor U. Laufs (Leipzig, DE) Professor L. Tokgozoglu (Ankara, TR) Professor S. Nicholls (Melbourne, AU)

Access the full session

Session thumbnail

Latest advancements in low-density lipoprotein cholesterol (LDL-C) lowering therapies and cardiovascular outcome trials

The Event

Event poster

ESC Congress 2023

26 August 2023 12:55 CET

You may be interested in

Congress Presentation

Lipid and secondary prevention 'up to date'

28 August 2023

Congress Presentation

LDL treatment-years: a new paradigm for cardiovascular risk reduction

1 September 2025

Congress Presentation

Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials

27 August 2021

Webinar

New trial evidence in the field of lipid management

19 April 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources